Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armitage, J. O.
Right arrow Articles by Weisenburger, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armitage, J. O.
Right arrow Articles by Weisenburger, D. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 16, 2780-2795, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

JO Armitage and DD Weisenburger
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-3332, USA.

Increasing knowledge about the biology of the non-Hodgkin's lymphomas has led to new approaches in classification. Rather than grouping lymphomas simply based on cell size, cell shape, and growth pattern, it is now possible to identify distinctive clinicopathologic entities. In many cases, the existence of specific immunologic and/or genetic features has confirmed the existence of these distinctive types of lymphoma. Since patients will be given these diagnoses by pathologists, it is important that clinicians be knowledgeable with regard to their clinical characteristics. The findings for the 13 most common lymphoma types that will be encountered in clinical practice are presented here.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
B. Dai, X. F. Zhao, P. Hagner, P. Shapiro, K. Mazan-Mamczarz, S. Zhao, Y. Natkunam, and R. B. Gartenhaus
Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
Cancer Res., October 1, 2009; 69(19): 7835 - 7843.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Bischof Delaloye, P. S. Conti, C. Gisselbrecht, and S. A. Gregory
Introduction
Oncologist, October 1, 2009; 14(suppl_2): 1 - 3.
[Full Text] [PDF]

Home page
 The OncologistHome page
A. J. Moskowitz and C. H. Moskowitz
Controversies in the Treatment of Lymphoma with Autologous Transplantation
Oncologist, September 1, 2009; 14(9): 921 - 929.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. S. Abramson, S. Digumarthy, and J. A. Ferry
Case 27-2009 -- A 56-Year-Old Woman with Fever, Rash, and Lymphadenopathy
N. Engl. J. Med., August 27, 2009; 361(9): 900 - 911.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. M. Al-Katib, A. Aboukameel, R. Mohammad, M.-C. Bissery, and C. Zuany-Amorim
Superior Antitumor Activity of SAR3419 to Rituximab in Xenograft Models for Non-Hodgkin's Lymphoma
Clin. Cancer Res., June 15, 2009; 15(12): 4038 - 4045.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. K. Gopal, J. M. Pagel, J. R. Fromm, S. Wilbur, and O. W. Press
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma
Blood, June 4, 2009; 113(23): 5905 - 5910.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Y. Zhao, A. Auerbach, A. M. D'Costa, A. P. Rapoport, A. M. Burger, E. A. Sausville, S. A. Stass, F. Jiang, A. M. Sands, N. Aguilera, et al.
Phospho-p70S6K/p85S6K and cdc2/cdk1 Are Novel Targets for Diffuse Large B-Cell Lymphoma Combination Therapy
Clin. Cancer Res., March 1, 2009; 15(5): 1708 - 1720.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Gyan, C. Foussard, P. Bertrand, P. Michenet, S. Le Gouill, C. Berthou, H. Maisonneuve, V. Delwail, R. Gressin, P. Quittet, et al.
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Blood, January 29, 2009; 113(5): 995 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
Ann. Onc., October 1, 2008; 19(10): 1774 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. D. Cheson and J. P. Leonard
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
N. Engl. J. Med., August 7, 2008; 359(6): 613 - 626.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Travert, P. Ame-Thomas, C. Pangault, A. Morizot, O. Micheau, G. Semana, T. Lamy, T. Fest, K. Tarte, and T. Guillaudeux
CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-{kappa}B Activation and Up-Regulation of c-FLIP and Bcl-xL
J. Immunol., July 15, 2008; 181(2): 1001 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Cartron, L. Zhao-Yang, M. Baudard, T. Kanouni, V. Rouille, P. Quittet, B. Klein, and J.-F. Rossi
Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Rituximab in Patients With Relapsed Follicular Lymphoma: Results of a Phase II Study
J. Clin. Oncol., June 1, 2008; 26(16): 2725 - 2731.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. G. Rajendran, A. K. Gopal, D. R. Fisher, L. D. Durack, T. A. Gooley, and O. W. Press
Myeloablative 131I-Tositumomab Radioimmunotherapy in Treating Non-Hodgkin's Lymphoma: Comparison of Dosimetry Based on Whole-Body Retention and Dose to Critical Organ Receiving the Highest Dose
J. Nucl. Med., May 1, 2008; 49(5): 837 - 844.
[Abstract] [Full Text] [PDF]

Home page
 J Bone Joint Surg BrHome page
L. Lidgren
Chronic inflammation, joint replacement and malignant lymphoma
J Bone Joint Surg Br, January 1, 2008; 90-B(1): 7 - 10.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
K. J. Savage
Prognosis and Primary Therapy in Peripheral T-Cell Lymphomas
Hematology, January 1, 2008; 2008(1): 280 - 288.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
D Talaulikar, J X Gray, B Shadbolt, M McNiven, and J E Dahlstrom
A comparative study of the quality of DNA obtained from fresh frozen and formalin-fixed decalcified paraffin-embedded bone marrow trephine biopsy specimens using two different methods
J. Clin. Pathol., January 1, 2008; 61(1): 119 - 123.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Daniel, B. Yang, D. A. Lawrence, K. Totpal, I. Balter, W. P. Lee, A. Gogineni, M. J. Cole, S. F. Yee, S. Ross, et al.
Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts
Blood, December 1, 2007; 110(12): 4037 - 4046.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
T. F. Bruno MD MSc and M. Donoff MD
Superior vena cava syndrome and telangiectasia in a man with lymphoma
Can. Med. Assoc. J., November 6, 2007; 177(10): 1177 - 1179.
[Full Text] [PDF]

Home page
 BloodHome page
C. Rodriguez-Antona, S. Leskela, M. Zajac, M. Cuadros, J. Alves, M. V. Moneo, C. Martin, J. C. Cigudosa, A. Carnero, M. Robledo, et al.
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas
Blood, November 1, 2007; 110(9): 3345 - 3351.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
D. J. Straus
How I Treat Mantle Cell Lymphoma
J. Oncol. Pract, September 1, 2007; 3(5): 281 - 282.
[Full Text] [PDF]

Home page
 NEJMHome page
G. S. Meyer, C. A. Hales, P. C. Amrein, A. Sharma, and R. L. Kradin
Case 26-2007 -- A 61-Year-Old Man with Recurrent Fevers
N. Engl. J. Med., August 23, 2007; 357(8): 807 - 816.
[Full Text] [PDF]

Home page
 BloodHome page
J. G. Gribben
How I treat indolent lymphoma
Blood, June 1, 2007; 109(11): 4617 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
H. Tsai, S Li, A. Ng, B Silver, M. Stevenson, and P. Mauch
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma
Ann. Onc., April 1, 2007; 18(4): 672 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Gratzinger, S. Zhao, R. J. Marinelli, A. V. Kapp, R. J. Tibshirani, A. S. Hammer, S. Hamilton-Dutoit, and Y. Natkunam
Microvessel Density and Expression of Vascular Endothelial Growth Factor and Its Receptors in Diffuse Large B-Cell Lymphoma Subtypes
Am. J. Pathol., April 1, 2007; 170(4): 1362 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. M. Mohammad, A. S. Goustin, A. Aboukameel, B. Chen, S. Banerjee, G. Wang, Z. Nikolovska-Coleska, S. Wang, and A. Al-Katib
Preclinical Studies of TW-37, a New Nonpeptidic Small-Molecule Inhibitor of Bcl-2, in Diffuse Large Cell Lymphoma Xenograft Model Reveal Drug Action on Both Bcl-2 and Mcl-1
Clin. Cancer Res., April 1, 2007; 13(7): 2226 - 2235.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
M. A. Shipp
Molecular Signatures Define New Rational Treatment Targets in Large B-Cell Lymphomas
Hematology, January 1, 2007; 2007(1): 265 - 269.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. Ghesquieres, F. Berger, P. Felman, E. Callet-Bauchu, P.-A. Bryon, A. Traverse-Glehen, C. Thieblemont, L. Baseggio, A.-S. Michallet, B. Coiffier, et al.
Clinicopathologic Characteristics and Outcome of Diffuse Large B-Cell Lymphomas Presenting With an Associated Low-Grade Component at Diagnosis
J. Clin. Oncol., November 20, 2006; 24(33): 5234 - 5241.
[Abstract] [Full Text] [PDF]

Home page
 ASH ANNUAL MEETING ABSTRACTSHome page
T. Kinoshita, T. Hotta, T. Shibata, K. Mukai, M. Yamaguchi, K. Tsukasaki, Y. Kagami, M. Kasai, K. Tobinai, and M. Shimoyama
Peripheral T-Cell Lymphoma-Unspecified (PTCL-U) and NK/T-Cell Lymphoma Showed a Significantly Poor Prognosis in a Randomized Controlled Trial (RCT) JCOG9002 with Multidrug Combination Chemotherapy for Aggressive Lymphoma.
Blood (ASH Annual Meeting Abstracts), November 1, 2006; 108(11): 2465 - 2465.
[Abstract] [PDF]

Home page
 BloodHome page
C. T. Rankin, M.-C. Veri, S. Gorlatov, N. Tuaillon, S. Burke, L. Huang, H. D. Inzunza, H. Li, S. Thomas, S. Johnson, et al.
CD32B, the human inhibitory Fc-{gamma} receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma
Blood, October 1, 2006; 108(7): 2384 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
O. W. Press, J. M. Unger, R. M. Braziel, D. G. Maloney, T. P. Miller, M. LeBlanc, and R. I. Fisher
Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911
J. Clin. Oncol., September 1, 2006; 24(25): 4143 - 4149.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Y. S. Jhanwar and D. J. Straus
The Role of PET in Lymphoma
J. Nucl. Med., August 1, 2006; 47(8): 1326 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. A. Stewart, N. Bahlis, K. Valentine, A. Balogh, L. Savoie, D. G. Morris, A. Jones, C. Brown, and J. A. Russell
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
Blood, June 15, 2006; 107(12): 4623 - 4627.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. S. Abramson
T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
Oncologist, April 1, 2006; 11(4): 384 - 392.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Chen, J. Houldsworth, A. B. Olshen, G. Nanjangud, S. Chaganti, E. S. Venkatraman, J. Halaas, J. Teruya-Feldstein, A. D. Zelenetz, and R. S. K. Chaganti
Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas
Blood, March 15, 2006; 107(6): 2477 - 2485.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Perea, A. Altes, S. Montoto, A. Lopez-Guillermo, E. Domingo-Domenech, A. Fernandez-Sevilla, J. M. Ribera, J. Grau, C. Pedro, J. Angel Hernandez, et al.
Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems
Ann. Onc., September 1, 2005; 16(9): 1508 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Abramson and M. A. Shipp
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
Blood, August 15, 2005; 106(4): 1164 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Deconinck, C. Foussard, N. Milpied, P. Bertrand, P. Michenet, P. Cornillet-LeFebvre, M. Escoffre-Barbe, H. Maisonneuve, V. Delwail, R. Gressin, et al.
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS
Blood, May 15, 2005; 105(10): 3817 - 3823.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. K. Ganti, P. J. Bierman, J. C. Lynch, R. G. Bociek, J. M. Vose, and J. O. Armitage
Hematopoietic stem cell transplantation in mantle cell lymphoma
Ann. Onc., April 1, 2005; 16(4): 618 - 624.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. J. F. Muris, S. A. G. M. Cillessen, W. Vos, I. S. van Houdt, J. A. Kummer, J. H. J. M. van Krieken, N. M. Jiwa, P. M. Jansen, H. C. Kluin-Nelemans, G. J. Ossenkoppele, et al.
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas
Blood, April 1, 2005; 105(7): 2916 - 2923.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Bamias, E. Efstathiou, L. A. Moulopoulos, D. Gika, G. Hamilos, M. P. Zorzou, C. Kakoyiannis, E. Kastritis, G. Bozas, C. Papadimitriou, et al.
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
Ann. Onc., February 1, 2005; 16(2): 307 - 313.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
F. Hagemeister, F. Cabanillas, M. Coleman, S. A. Gregory, and P. L. Zinzani
The Role of Mitoxantrone in the Treatment of Indolent Lymphomas
Oncologist, February 1, 2005; 10(2): 150 - 159.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Morris, K. Thomson, C. Craddock, P. Mahendra, D. Milligan, G. Cook, G. M. Smith, A. Parker, S. Schey, R. Chopra, et al.
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
Blood, December 15, 2004; 104(13): 3865 - 3871.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. S. Dave, G. Wright, B. Tan, A. Rosenwald, R. D. Gascoyne, W. C. Chan, R. I. Fisher, R. M. Braziel, L. M. Rimsza, T. M. Grogan, et al.
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
N. Engl. J. Med., November 18, 2004; 351(21): 2159 - 2169.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. O. Armitage, J. M. Vose, and D. D. Weisenburger
Towards understanding the peripheral T-cell lymphomas
Ann. Onc., October 1, 2004; 15(10): 1447 - 1449.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. W. Friedberg
Developing New Monoclonal Antibodies for Aggressive Lymphoma: A Challenging Road in the Rituximab Era
Clin. Cancer Res., August 15, 2004; 10(16): 5297 - 5298.
[Full Text] [PDF]

Home page
 JCOHome page
A.J. Davies, A.Z.S. Rohatiner, S. Howell, K.E. Britton, S.E. Owens, I.N. Micallef, D.P. Deakin, B.M. Carrington, J.A. Lawrance, S. Vinnicombe, et al.
Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin's Lymphoma
J. Clin. Oncol., April 15, 2004; 22(8): 1469 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Enblad, H. Hagberg, M. Erlanson, J. Lundin, A. P. MacDonald, R. Repp, J. Schetelig, G. Seipelt, and A. Osterborg
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
Blood, April 15, 2004; 103(8): 2920 - 2924.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
E. Weidmann, M. Gramatzki, M. Wilhelm, and P. S. Mitrou
Diagnosis and actual therapy strategies in peripheral T-cell lymphomas: summary of an international meeting
Ann. Onc., March 1, 2004; 15(3): 369 - 374.
[Full Text] [PDF]

Home page
 BloodHome page
J. Houldsworth, A. B. Olshen, G. Cattoretti, G. B. Donnelly, J. Teruya-Feldstein, J. Qin, N. Palanisamy, Y. Shen, K. Dyomina, M. Petlakh, et al.
Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas
Blood, March 1, 2004; 103(5): 1862 - 1868.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. F. Khouri, M.-S. Lee, R. M. Saliba, G. Jun, L. Fayad, A. Younes, B. Pro, S. Acholonu, P. McLaughlin, R. L. Katz, et al.
Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell Lymphoma
J. Clin. Oncol., December 1, 2003; 21(23): 4407 - 4412.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. M. Mohammad, A. Al-Katib, A. Aboukameel, D. R. Doerge, F. Sarkar, and O. Kucuk
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Mol. Cancer Ther., December 1, 2003; 2(12): 1361 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. W. Tsang, M. K. Gospodarowicz, M. Pintilie, W. Wells, D. C. Hodgson, A. Sun, M. Crump, and B. J. Patterson
Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome
J. Clin. Oncol., November 15, 2003; 21(22): 4157 - 4164.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. S. Lima, E. B. Leite, R. P. Fonseca, and A. S. Fernandes Jr
Patients Presenting With CNS Lesions: CASE 1. PRIMARY LOW-GRADE MUCOSA-ASSOCIATED B-CELL LYMPHOMA OF THE DURA
J. Clin. Oncol., November 1, 2003; 21(21): 4058 - 4060.
[Full Text] [PDF]

Home page
 BloodHome page
A. K. Gopal, T. A. Gooley, D. G. Maloney, S. H. Petersdorf, J. F. Eary, J. G. Rajendran, S. A. Bush, L. D. Durack, J. Golden, P. J. Martin, et al.
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
Blood, October 1, 2003; 102(7): 2351 - 2357.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
R. M. Gowda and I. A. Khan
Clinical Perspectives of Primary Cardiac Lymphoma
Angiology, September 1, 2003; 54(5): 599 - 604.
[Abstract] [PDF]

Home page
 BloodHome page
O. W. Press, J. M. Unger, R. M. Braziel, D. G. Maloney, T. P. Miller, M. LeBlanc, E. R. Gaynor, S. E. Rivkin, and R. I. Fisher
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
Blood, September 1, 2003; 102(5): 1606 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. M. Gianni, M. Magni, M. Martelli, M. Di Nicola, C. Carlo-Stella, S. Pilotti, A. Rambaldi, S. Cortelazzo, C. Patti, G. Parvis, et al.
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)
Blood, July 15, 2003; 102(2): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. W. Last, V. Cornelius, T. Delves, C. Sieniawska, J. Fitzgibbon, A. Norton, J. Amess, A. Wilson, A. Z.S. Rohatiner, and T. A. Lister
Presentation Serum Selenium Predicts for Overall Survival, Dose Delivery, and First Treatment Response in Aggressive Non-Hodgkin's Lymphoma
J. Clin. Oncol., June 15, 2003; 21(12): 2335 - 2341.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. S. J. Elenitoba-Johnson, S. D. Jenson, R. T. Abbott, R. A. Palais, S. D. Bohling, Z. Lin, S. Tripp, P. J. Shami, L. Y. Wang, R. W. Coupland, et al.
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy
PNAS, June 10, 2003; 100(12): 7259 - 7264.
[Abstract] [Full Text] [PDF]

Home page
 J. Nucl. Med. Technol.Home page
D. M. Fink-Bennett and K. Thomas
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
J. Nucl. Med. Technol., June 1, 2003; 31(2): 61 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Damaj, V. Verkarre, A. Delmer, P. Solal-Celigny, I. Yakoub-Agha, C. Cellier, F. Maurschhauser, R. Bouabdallah, V. Leblond, F. Lefrere, et al.
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review
Ann. Onc., April 1, 2003; 14(4): 623 - 629.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Franco, A. M. Florena, and E. Iannitto
Splenic marginal zone lymphoma
Blood, April 1, 2003; 101(7): 2464 - 2472.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. E. Levine, R. E. Harris, F. R. Loberiza Jr, J. O. Armitage, J. M. Vose, K. Van Besien, H. M. Lazarus, and M. M. Horowitz
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma
Blood, April 1, 2003; 101(7): 2476 - 2482.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
B. Sanchez-Vega, F. Vega, L. J. Medeiros, M. S. Lee, and R. Luthra
Quantification of bcl-2/JH Fusion Sequences and a Control Gene by Multiplex Real-Time PCR Coupled with Automated Amplicon Sizing by Capillary Electrophoresis
J. Mol. Diagn., November 1, 2002; 4(4): 223 - 229.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. O. Dillman
Radiolabeled Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoma
J. Clin. Oncol., August 15, 2002; 20(16): 3545 - 3557.
[Full Text] [PDF]

Home page
 Ann OncolHome page
E. Maartense, S. le Cessie, H. C. Kluin-Nelemans, P. M. Kluin, S. Snijder, P. W. Wijermans, and E. M. Noordijk
Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry
Ann. Onc., August 1, 2002; 13(8): 1275 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Ott, T. Katzenberger, A. Lohr, S. Kindelberger, T. Rudiger, M. Wilhelm, J. Kalla, A. Rosenwald, J. G. Muller, M. M. Ott, et al.
Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3
Blood, May 15, 2002; 99(10): 3806 - 3812.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. K. Gopal, J. G. Rajendran, S. H. Petersdorf, D. G. Maloney, J. F. Eary, B. L. Wood, T. A. Gooley, S. A. Bush, L. D. Durack, P. J. Martin, et al.
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma
Blood, May 1, 2002; 99(9): 3158 - 3162.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Achten, G. Verhoef, L. Vanuytsel, and C. De Wolf-Peeters
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Distinct Clinicopathologic Entity
J. Clin. Oncol., March 1, 2002; 20(5): 1269 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Filipits, U. Jaeger, G. Pohl, T. Stranzl, I. Simonitsch, A. Kaider, C. Skrabs, and R. Pirker
Cyclin D3 Is a Predictive and Prognostic Factor in Diffuse Large B-cell Lymphoma
Clin. Cancer Res., March 1, 2002; 8(3): 729 - 733.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. M. Timmerman, D. K. Czerwinski, T. A. Davis, F. J. Hsu, C. Benike, Z. M. Hao, B. Taidi, R. Rajapaksa, C. B. Caspar, C. Y. Okada, et al.
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
Blood, March 1, 2002; 99(5): 1517 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
T. Rudiger, D. D. Weisenburger, J. R. Anderson, J. O. Armitage, J. Diebold, K. A. MacLennan, B. N. Nathwani, F. Ullrich, and H. K. Muller-Hermelink
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project
Ann. Onc., January 19, 2002; 13(1): 140 - 149.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. M. Braziel, D. A. Arber, M. L. Slovak, M. L. Gulley, C. Spier, C. Kjeldsberg, J. Unger, T. P. Miller, R. Tubbs, C. Leith, et al.
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features
Blood, June 15, 2001; 97(12): 3713 - 3720.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. W. Sweetenham, G. Santini, W. Qian, M. Guelfi, N. Schmitz, S. Simnett, A. Nagler, H. Holte, S. Kvaloy, P. Bruzzi, et al.
High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional-Dose Consolidation/Maintenance Therapy as Postremission Therapy for Adult Patients With Lymphoblastic Lymphoma: Results of a Randomized Trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group
J. Clin. Oncol., June 1, 2001; 19(11): 2927 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Akpek, E. K. Akpek, S. Li, R. W. Green, T. P. O'Brien, and M. J. Borowitz
Unusual Locations for Lymphomas: Case 3. Successive Occurrence of Peripheral T-Cell Lymphoma With Bilateral Conjuctival Involvement in a Patient With Low-Grade B-Cell Lymphoma
J. Clin. Oncol., May 1, 2001; 19(11): 2964 - 2966.
[Full Text] [PDF]

Home page
 BloodHome page
R. Suzuki, Y. Kagami, K. Takeuchi, M. Kami, M. Okamoto, R. Ichinohasama, N. Mori, M. Kojima, T. Yoshino, H. Yamabe, et al.
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
Blood, November 1, 2000; 96(9): 2993 - 3000.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. D. Hainsworth
Monoclonal Antibody Therapy in Lymphoid Malignancies
Oncologist, October 1, 2000; 5(5): 376 - 384.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
M. Filipits, U. Jaeger, I. Simonitsch, C. Chizzali-Bonfadin, H. Heinzl, and R. Pirker
Clinical Relevance of the Lung Resistance Protein in Diffuse Large B-Cell Lymphomas
Clin. Cancer Res., September 1, 2000; 6(9): 3417 - 3423.
[Abstract] [Full Text]

Home page
 BloodHome page
C. Adida, C. Haioun, P. Gaulard, E. Lepage, P. Morel, J. Briere, H. Dombret, F. Reyes, J. Diebold, C. Gisselbrecht, et al.
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
Blood, September 1, 2000; 96(5): 1921 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Corcione, L. Ottonello, G. Tortolina, P. Facchetti, I. Airoldi, R. Guglielmino, P. Dadati, M. Truini, S. Sozzani, F. Dallegri, et al.
Stromal Cell-Derived Factor-1 as a Chemoattractant for Follicular Center Lymphoma B Cells
J Natl Cancer Inst, April 19, 2000; 92(8): 628 - 635.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. D. Remstein, C. D. James, and P. J. Kurtin
Incidence and Subtype Specificity of API2-MALT1 Fusion Translocations in Extranodal, Nodal, and Splenic Marginal Zone Lymphomas
Am. J. Pathol., April 1, 2000; 156(4): 1183 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Federico, U. Vitolo, P. L. Zinzani, T. Chisesi, V. Clo, G. Bellesi, M. Magagnoli, M. Liberati, C. Boccomini, P. Niscola, et al.
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases
Blood, February 1, 2000; 95(3): 783 - 789.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online